Value for Money in Ukraine’s HIV Response : Strategic Investment and Improved Efficiency
Ukraine experiences one of the most severe HIV epidemics in Europe. An HIV allocative efficiency analysis has been carried out, which revealed that there are several key opportunities to change the course of Ukraine’s HIV epidemic:Ukraine’s current...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | English en_US |
| Published: |
World Bank, Washington, DC
2016
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2016/07/26570650/value-money-ukraine’s-hiv-response-strategic-investment-improved-efficiency http://hdl.handle.net/10986/24967 |
| Summary: | Ukraine experiences one of the most
severe HIV epidemics in Europe. An HIV allocative efficiency
analysis has been carried out, which revealed that there are
several key opportunities to change the course of Ukraine’s
HIV epidemic:Ukraine’s current HIV response already makes
strategic use of available resources (around US$80 million
in 2013) prioritizing Antiretroviral Therapy (ART) and
prevention programs for people who inject drugs (PWID), men
who have sex with men (MSM) and female sex workers (FSW).
This investment, which successfully stabilized the epidemic
– although at a high level – is unlikely to lead to further
declines in new infections and deaths. The number of people
on ART could be doubled to 130,000 (around 60 percent of all
PLHIV) within the stipulated annual budget. At the time of
completion of this study (mid 2015), only around 30 percent
of Ukraine’s estimated 223,000 PLHIV received treatment
against a global target of 81 percent by 2020. There is need
to implement efficient and effective ART scale-up, achieve
the national target of 118,240 PLHIV on ART by 2018, and
plan for further increasing coverage to reach global targets
- with a strong focus on HIV diagnosis among key
populations.Continued funding for prevention programs for
key populations remains critical beyond 2018.There is need
for enhanced integration of HIV services with services for
Tuberculosis, drug use treatment including Opioid
Substitution Therapy, blood-borne viruses and sexual
health.Ukraine’s HIV response requires a shared long-term
vision on sustainable HIV financing and needs to harness the
wider health sector reforms and emerging financing models.
This policy brief is a result of a team effort involving the
State Institution Ukrainian Center for Socially Dangerous
Disease Control of the MOH of Ukraine and international
partners. The study was part of the regional initiatives on
HIV allocative efficiency analysis and funded and
technically supported by the World Bank and UNAIDS. We
greatly acknowledge the contributions of all the team
members, stakeholders and other partners. There are major
opportunities, but also major risks in relation to HIV
investment decisions in Ukraine in the coming five years.
While decreasing funding would lead to a marked increase in
deaths, new infections and future health care costs, a smart
approach to increasing HIV investment, could avert around
half of the new infections and deaths up to 2030 compared to
business as usual. |
|---|